Smarca4-deficient Tumor
📧 Sign up to get email alerts when something new happens for Smarca4-deficient Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors [Phase 1]
Eli Lilly's LY4050784 is being studied in a Phase 1 trial for advanced or metastatic solid tumors and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: A Retrospective Cohort Analysis of SMARCA4-Deficient Lung Cancer
This study retrospectively analyzes patients with SMARCA4-deficient tumors, including advanced non-small cell lung cancer, to describe clini…